Barbara Gayle Duncan stock trades
Director at Atea Pharmaceuticals and Halozyme Therapeutics
No open-market buys or sales reported in the last 12 months. Their newest Form 4, for Jun 18: stock unit conversion (29,600 AVIR shares).
The 2 companies Barbara Gayle Duncan files at
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 0 | ||
| 0 |
Barbara Gayle Duncan's trades, as filed
None on the open market in the last 12 months.
2 other filings on record (stock award and stock unit conversion). Pro members see every filing and the shares Barbara Gayle Duncan holds.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Others who file at their companies
- Jean-Pierre Sommadossi
- Andrea Corcoran
- Janet Mj Hammond
- John Vavricka
- Maria Arantxa Horga
- Wayne Foster
- Bruce Polsky
- Bruno Lucidi
- Franklin M. Berger
- Jerome M. Adams
- Polly A. Murphy
- Helen Torley
- Nicole LaBrosse
- Cortney Caudill
- David A. Ramsay
- Mark Howard Snyder
- Bernadette Connaughton
- Matthew L. Posard
- Mahesh Krishnan
- Dannielle Appelhans
- James M. Daly
- James Paul Lang
- Jeffrey William Henderson